KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

F5 (FFIV) Research & Development (2016 - 2025)

Historic Research & Development for F5 (FFIV) over the last 17 years, with Q4 2025 value amounting to $141.2 million.

  • F5's Research & Development rose 815.44% to $141.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $550.5 million, marking a year-over-year increase of 985.8%. This contributed to the annual value of $539.8 million for FY2025, which is 1013.94% up from last year.
  • Per F5's latest filing, its Research & Development stood at $141.2 million for Q4 2025, which was up 815.44% from $136.4 million recorded in Q3 2025.
  • In the past 5 years, F5's Research & Development registered a high of $142.3 million during Q4 2022, and its lowest value of $119.6 million during Q4 2023.
  • For the 5-year period, F5's Research & Development averaged around $132.7 million, with its median value being $134.6 million (2021).
  • As far as peak fluctuations go, F5's Research & Development soared by 2882.29% in 2021, and later tumbled by 1598.34% in 2023.
  • Quarter analysis of 5 years shows F5's Research & Development stood at $130.3 million in 2021, then increased by 9.25% to $142.3 million in 2022, then dropped by 15.98% to $119.6 million in 2023, then increased by 9.15% to $130.5 million in 2024, then grew by 8.15% to $141.2 million in 2025.
  • Its Research & Development stands at $141.2 million for Q4 2025, versus $136.4 million for Q3 2025 and $136.3 million for Q2 2025.